leisure time -WSS

leisure time

author：leisure time 2025-10-02 22:27:14 - browse：17658

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Diversify hospital leadership teams to protect BIPOC patient health

leisure time

focus

WSS

FDA approves potent Eli Lilly obesity drug, Zepbound

Victims of gun violence feel impacts long after bullet wound

Free speech concerns arise in wake of journal editor Eisen's firing

Study: New antibiotic targets gonorrhea as well as last existing drug

FDA has safety concerns on CRISPR

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

entertainment

leisure time

explore

What does generative AI mean for health care? We asked experts

FDA approves potent Eli Lilly obesity drug, Zepbound

Jerome Adams on the need for new antivirals for Covid

More doctors should go into startup world

Hepatitis C has a cure — but many Americans still lack access to it

A clever new way to fix Medicaid and graduate medical education

Apple is now the first public company to be valued at $3 trillion

Diversifying clinical trials isn't enough to close racial gaps: study

Wildfire smoke exposes gaps in outdoor worker protections

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

hotspot

UCSF medical school apologizes for unethical prisoner experiments

Extreme heat events are a public health emergency

More doctors should go into startup world

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Biden's order seeks to regulate AI risk without stifling innovation

The FDA weighs the risks of candy

leisure time

focus

hotspot

focus